Expanding Role of India in the Global Biotechnology Landscape

Expanding Role of India in the Global Biotechnology Landscape

Unleashing the Indian Biotech Boom

India's biotech sector has exploded in growth, skyrocketing from a mere $10 billion in 2014 to a breathtaking $165.7 billion in 2024. And it's not just the money talk; biotech startups in India have multiplied by an astronomical 200 times, jumping from a handful to more than 10,075 today!

Fueling this meteoric rise, a thriving ecosystem of public-private partnerships, highly skilled human capital, burgeoning infrastructure, and robust policy support serves as the perfect launchpad for the Indian biotech sector.

When it comes to policy, the Indian government has introduced game-changing initiatives like the BioE3 Policy and National Biopharma Mission in 2024. The BioE3 Policy, aiming for Biotechnology for Economy, Employment, and Environment, promotes research, innovation, and entrepreneurship through initiatives such as Bio-AI Hubs, Bio foundries, and Bio-Enabler Hubs.

The National Biopharma Mission (NBM), a collaboration between industry and academia, empowers India's biopharmaceutical sector by focusing on four essential areas: developing affordable product leads for vaccines, biosimilars, and medical devices; upgrading shared infrastructure facilities; honing human capital by eliminating skill gaps; and fostering technology transfer offices for translating knowledge into products and technologies.

In a bid to support and expand the burgeoning startup ecosystem in the biotech sector, India launched the Bio-Saarthi program in 2025. This global mentorship initiative offers six months of personalized guidance to entrepreneurial leaders in the biotech sector, bridging the gap between academia and industry, and positioning Indian startups for international success.

Embracing overseas expertise, particularly through the involvement of the Indian diaspora, is a crucial aspect of India's biotech policy. Leveraging global Indian-origin mentors offers valuable insights and guidance to emerging biotech entrepreneurs in India.

India's demographic dividend plays a significant role in the steady growth of the biotech sector, with rising purchasing power, an aging population, and a highly fertile young population—47 percent under 25—creating a ripe environment for biotech innovation. This, coupled with the influx of MNCs such as AstraZeneca, GSK, Eli Lilly, and Bayer establishing Global Capability Centers (GCCs) in India, places the country at the forefront of the life sciences sector.

India's biotech prowess is also rooted in its digital transformation, harnessing the power of AI, Big Data, IoT, machine learning (ML), and other digital technologies. The integration of AI in R&D within the Indian pharma sector has made advancements affordable, allowing companies to tap into economies of scale. Solutions like digital manufacturing of drugs and reduced go-to-market times have revolutionized the pharma sector, ushering in an era of precision medicine. With its success in the sector, India accrues the title of the "pharmacy of the world," serving as a global supplier of generic medicine for over 200 countries.

Over the last three years, extensive efforts on the part of both government and private entities have been made to expand growth in this sector. Biotech parks have been established, and collaborations with international biotech institutions have been initiated. Focusing on inclusive growth, the Department of Biotechnology concentrates on its North Eastern Programme, aiming to foster biotech-based development in the North East India through collaborating Institutes from the region with other leading Institutions across the country.

The success of the Indian biotech industry lies in the growth of its startups and the advancement of R&D, which is facilitated by comprehensive and supportive policies and public-private partnerships. So, there's been a concerted push to increase the number of biotech incubators. With its vast contributors to the economy, exponential startup growth, and burgeoning human capital, India's biotech ecosystem stands to offer panacea in various domains, including health, agriculture, and the environment.

1. Biotech startups in India have grown exponentially, increasing by 200 times from a handful to over 10,075 due to a supportive ecosystem of public-private partnerships, skilled human capital, infrastructure, and policy support.
2. The Indian government has introduced initiatives like the BioE3 Policy and National Biopharma Mission to promote research, innovation, and entrepreneurship, and to upgrade shared infrastructure facilities, eliminate skill gaps, and foster technology transfer.
3. In 2025, India launched the Bio-Saarthi program, a global mentorship initiative offering personalized guidance to biotech entrepreneurs, bridging the gap between academia and industry.
4. Embracing overseas expertise has been a crucial aspect of India's biotech policy, with global Indian-origin mentors offering valuable insights and guidance to emerging biotech entrepreneurs.
5. India's biotech sector growth is fueled by factors such as its large youth population, rising purchasing power, and an aging population, creating a conducive environment for biotech innovation.
6. India's success in the biotech sector is also attributed to its digital transformation, with the integration of AI, Big Data, IoT, and machine learning revolutionizing R&D and manufacturing processes, leading to an era of precision medicine.
7. Efforts have been made to expand the biotech sector, including establishing biotech parks, collaborating with international biotech institutions, and increasing the number of biotech incubators, aiming to foster biotech-based development in all regions of the country.

Read also: